FDA Review of Abortion Pill Complications

SOURCE www.breitbart.com
HHS Secretary Robert F. Kennedy Jr. orders FDA review of abortion pill due to higher complication rates than reported, prompting calls for reinstating earlier safeguards. Study found severe complications in 10.93% of cases, much higher than FDA-reported rate of less than 0.5%.

Key Points

  • Study found 10.93% of women had severe complications after mifepristone abortions
  • Calls for reinstating safeguards around mifepristone due to safety concerns
  • FDA under scrutiny for lack of reporting and potential risks to women's health

Pros

  • Increased transparency on abortion pill safety
  • Potential for reinstating safeguards to protect women's health

Cons

  • Higher complication rates than previously reported
  • Potential risks to women's health due to lack of reporting and telehealth access